Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

Pot Pharm: Booming Canada weed sector plots next-wave medicines

Canopy Growth Corp., one of the world's biggest medical marijuana producers, now wants to take on the world's pharmaceutical giants. (28-0)

Has OrganiGram Entered The Twilight Zone Of Canadian Pot Stocks?

2018-02-16 seekingalpha
OrganiGram (OTCQB:OGRMF) sits in one of the more unique positions in the Canadian cannabis sector. It is one of the largest mid-size companies in the market, and is likely to maintain that position over the next year or two, unless it decides to change its domestic business model. (18-0)

CANADA STOCKS-TSX little changed as energy companies tempered by gold sector

2018-02-16 reuters
Feb 16 (Reuters) - Canada’s main stock index was little changed on Friday as a boost from the heavyweight energy sector was offset by a decline in gold and natural resource companies, as well as cannabis producers. (47-0)

RPT-INSIGHT-Pot Pharm: Booming Canada weed sector plots next-wave medicines

2018-02-16 reuters
TORONTO, Feb 16 (Reuters) - Canopy Growth Corp, one of the world’s biggest medical marijuana producers, now wants to take on the world’s pharmaceutical giants. (28-0)

Pot Pharm: Booming Canada weed sector plots next-wave medicines

2018-02-16 reuters
TORONTO (Reuters) - Canopy Growth Corp, one of the world’s biggest medical marijuana producers, now wants to take on the world’s pharmaceutical giants. (28-0)

What Were Canopy Growth’s 3Q18 Sales Drivers?

Sales volume, mix, and selling prices are key drivers for Canopy Growth’s (WEED) sales as well as for companies (HMLSF) such as Aphria (APHQF), Aurora Cannabis (ACBFF), and MedReleaf (MEDFF). Let’s look at how Canopy Growth performed on these fronts. (18-0)

Canopy Growth Saw Significant Reduction in Cost per Gram in 3Q18

In the earlier part of this series, we discussed Canopy Growth’s sales drivers and how the company’s selling prices increased year-over-year. At the same time, the company also managed to lower its cost of production. In its press release, Canopy Growth reported that its per gram weighted average cost before shipping and fulfillment fell 39% to 1.03 Canadian dollars from 1.7 Canadian dollars in 3Q17. (18-0)

How Canopy Growth’s Margins Looked in 3Q18

In the earlier parts of this series, we discussed how Canopy Growth (WEED) fared in terms of selling prices, sales volumes, and cost of production. While the company’s cost of production fell 1.9% year-over-year, its selling price rose 13% over the same period. (18-0)

How Canopy Growth Is Preparing for Legalized Cannabis

In preparation for the expected legalization of recreational cannabis in Canada, Canopy Growth’s (WEED) chair and CEO Bruce Linton stated, “Success in future global medical markets and the recreational cannabis market in Canada will depend not only on capacity but on strong execution and securing supply agreements with the provinces today.” (18-0)

How Recreational Cannabis Pricing in Canada Could Shape Up

There has been a great deal of enthusiasm recently among investors (MJX) when it comes to cannabis stocks. Of course, the biggest catalyst for sales growth has come from recreational use in Canada. In addition, an increase in medical and recreational cannabis use around the world may also drive sales growth for these companies. (18-0)

Six marijuana companies announce deals to supply Quebec with cannabis

2018-02-14 thestar
This copy is for your personal non-commercial use only. To order presentation-ready copies of Toronto Star content for distribution to colleagues, clients or customers, or inquire about permissions/licensing, please go to: (14-1)

BRIEF-Aurora Cannabis Signed LoI With Société Des Alcools Du Québec

2018-02-14 reuters

Aurora Cannabis: Firing On All Cylinders

2018-02-13 seekingalpha
Aurora Cannabis (OTCQX:ACBFF) reported its second quarter fiscal 2018 results last week. The cannabis industry has been in the spotlight lately as investors focus on the upcoming legalization. The current medical market is expected to expand but the recreational market represents the bulk of the eventual consumption. Aurora is currently building out its Aurora Sky facility and its pending acquisition of CanniMed (OTC:CMMDF) will further boost its production profile and customer base. (18-0)

Growing Ganja In Gatineau: Can Hydropothecary Dominate Quebec Cannabis?

2018-02-13 seekingalpha
Future value will depend on THCX's ability to sell tens of thousands of kilograms of cannabis, while they currently sell 120 kg/quarter. (19-1)

Where We Are In The Cannabis Stock Market Cycle

2018-02-13 seekingalpha
The cannabis stocks are transitioning from the first stage of the bull market to the second stage. This means investors should change their portfolio strategy. (21-4)

ACBFF : Aurora Cannabis (TSXV:ACB) Analysis and Research Report

Aurora Cannabis is a community minded, Canadian owned and operated company. Nestled in the shadow of the Rockies in Mountain View County, its plants are carefully brought to harvest in its purpose-built 55,200 square foot facility.

Fed with water from the Canadian Rockies, cared for in a state-of-the-art facility designed to produce the cleanest, safest medical cannabis available on the market, we're proud of its facility, its team and its product. Cultivating, harvesting, and selling Canadian Medical Marijuana, Aurora is your best chance to experience the healing power of nature.

On November 27th, 2015 Aurora was officially issued its license to sell. This marked a monumental step in the continued success and evolution of Aurora as one of Canada's top medical marijuana companies.

Aurora is one of 35 licensed producers across Canada and the only one located in Alberta. Boasting the second highest square footage approved for production in Canada, Aurora was the first applicant ...

Click for full article
CUSIP: 05156X108